Amylin Pharmaceuticals (AMLN) Sees Late Day Pressure
Tweet Send to a FriendGet Alerts AMLN Hot Sheet
Up)
Trade AMLN Now!
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) sees downside action late in the session. Share are down 3%.
In March the company rejected a $22 share bid from Brisol-Myers (NYSE: BMY), although others are said to come with higher bids.
Today's action suggest some may be dropping out of the bidding, although we haven't seen anything official.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
In March the company rejected a $22 share bid from Brisol-Myers (NYSE: BMY), although others are said to come with higher bids.
Today's action suggest some may be dropping out of the bidding, although we haven't seen anything official.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Chile regulators stopped build, imposed sanctions on Barrick Gold (ABX)
- UPDATE: Fannie Mae, Freddie Mac Surge as Seriously Delinquent Rate Falls Below 3%
- Vivus (VVUS) Sees Upside on Icahn Connection
Create E-mail Alert Related Categories
Rumors, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
